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Background: Hearing depends on correct functioning of the cochlear hair cells, and their innervation by spiral
ganglion neurons. Most of the insight into the embryological and molecular development of this sensory system
has been derived from animal studies. In contrast, little is known about the molecular expression patterns and
dynamics of signaling molecules during normal fetal development of the human cochlea. In this study, we
investigated the onset of hair cell differentiation and innervation in the human fetal cochlea at various stages
of development.
Results: At 10 weeks of gestation, we observed a prosensory domain expressing SOX2 and SOX9/SOX10 within the
cochlear duct epithelium. In this domain, hair cell differentiation was consistently present from 12 weeks, coinciding
with downregulation of SOX9/SOX10, to be followed several weeks later by downregulation of SOX2. Outgrowing
neurites from spiral ganglion neurons were found penetrating into the cochlear duct epithelium prior to hair cell
differentiation, and directly targeted the hair cells as they developed. Ubiquitous Peripherin expression by spiral
ganglion neurons gradually diminished and became restricted to the type II spiral ganglion neurons by 18 weeks.
At 20 weeks, when the onset of human hearing is thought to take place, the expression profiles in hair cells and
spiral ganglion neurons matched the expression patterns of the adult mammalian cochleae.
Conclusions: Our study provides new insights into the fetal development of the human cochlea, contributing to
our understanding of deafness and to the development of new therapeutic strategies to restore hearing.
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The cochlea houses two of the main cell types respon-
sible for hearing: the hair cells and the spiral ganglion
neurons (SGNs). Damage to the cochlea is usually asso-
ciated with degeneration and irreversible loss of these
cell types, which ultimately leads to permanent sensori-
neural hearing loss, the most common type of deafness
[1,2]. In order to develop new therapeutic strategies, it is
essential to have a better understanding of the normal
molecular development of the human cochlea.
In the human embryo, the otic placode invaginates to
form the otic vesicle (or otocyst) during week 6 of gesta-
tion (W6), equivalent to week 4 of fetal development [3].
In the subsequent weeks, the otic vesicle develops into* Correspondence: lopes@lumc.nl
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reproduction in any medium, provided the orboth the vestibular organs and the cochlea. The cochlear
duct spirals around a central axis, and reaches its final
2.5 turns by W10 to W11 [4,5]. At this stage, the epithe-
lial lining of the cochlear duct is still undifferentiated. In
mice, a dedicated area within the epithelium of the coch-
lear duct floor has been identified as the ‘prosensory do-
main’ [6]; this contains the precursors to the inner hair
cells (IHCs), the outer hair cells (OHCs), and various
types of surrounding supporting cells, which together
form the organ of Corti (OC) [7,8]. The prosensory do-
main is flanked by two other domains: Kölliker’s organ
(KO) and the future outer sulcus. Although the prosensory
domain has not been formally described in humans, hair
cells are first visible by W12 in the human fetus in the re-
gion where the OC will form [5]. The OC reaches its gross
adult morphology around W20, which corresponds to the
onset of auditory function [9-11].Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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coincides with the establishment of highly specialized in-
nervation patterns by afferent type I and type II SGNs.
In humans, multiple type I SGNs innervate single IHCs
in a ‘radial’ organization, and make up 90 to 95% of the
total population of SGNs, whereas single type II SGNs
contact multiple OHCs in a ‘spiral’ organization [12]. In
mice, SGNs project to both IHCs and OHCs until 6 to
7 days after birth, when a clear distinction between type I
and type II ganglion neurons takes place, just prior to the
onset of hearing (post-natal week 2) [13,14]. In humans,
penetration of the SGN neurites into the cochlear neuro-
epithelium has been observed earlier than the first dif-
ferentiation of hair cells by electron microscopy [5].
The peripheral neurites of the SGNs penetrate the
basal turn around W11, and in the following weeks
find their way to the developing hair cells and shape
their synaptic connections [5,15]. However, the separation
of type I and type II SGNs has not been investigated in
humans.
Here, we investigated both the dynamics of develop-
ment of human cochlear hair cells and their innervation.
The spatial and temporal dynamics of hair cell differenti-
ation was determined by examining the expression of
three members of the SOX family, a group of genes in-
volved with cell fate decisions: SOX2, SOX9, and SOX10.
An example of early cell fate specification in the coch-
lear duct epithelium is the spatially restricted expression
of SOX2 to the cells of the prosensory domain [8]. The
functional importance of the SOX2 transcription factor in
normal cochlear development is further illustrated by fail-
ure of the prosensory domain establishment in loss-of-
function conditions [8], and underdevelopment of hair
cells in gain-of-function conditions [16]. Sox9 and Sox10
are known to be expressed in the otic placode and the
otic vesicle in frog and chick [17-20]. In mice, SOX9 is
also expressed in the otic placode and otic vesicle and
controls invagination [21], and both SOX9 and SOX10
have been found in the mouse cochlear duct epithelium
[22-26]. Interestingly, in mice, Sox9 and Sox10 are
downregulated before or upon hair cell differentiation,
whereas Sox2 is downregulated gradually, although all
three Sox genes remain expressed in the underlying
supporting cells in the OC [8,22,23].
In humans, SOX2, SOX9, and SOX10 are likely to play
an important role in cochlear development, as mutations
in all three genes have been shown to cause sensori-
neural hearing loss [27-29]. However, although SOX10
expression has been reported in the human otic vesicle
[30], expression patterns of these SOX transcription fac-
tors, and their dynamics upon hair cell differentiation,
have not previously been determined in the (developing)
human cochlea. In addition, the innervation of the IHCs and
OHCs was in the current study investigated by comparingthe dynamics of expression of Peripherin (PRPH), an inter-
mediate filament protein that is expressed in type II SGNs,
both in adult mouse and adult human cochleae [13,31],
along with the expression of class III β-Tubulin (TUBB3), a
general SGN marker. The comprehensive description of the
molecular and morphological events taking place in the
cochlea as functional hearing develops may benefit the de-
velopment of strategies for cochlear repair.
Results
The human prosensory domain is SOX2-positive
To determine whether a prosensory domain also exists
during human development, we investigated the expres-
sion of SOX2 at W10.4 (week 10 and 4 days), a stage
when the cochlear duct epithelium showed no clear
morphological hair cell specification (Figure 1A). At this
point, nuclear SOX2 expression was already restricted to
the human prosensory domain (Figure 1B) and no ex-
pression was visible in other parts of the cochlear duct,
except for cytoplasmic SOX2 expression in the lateral
wall of the cochlear duct epithelium (Figure 1B, aster-
isk). At W10.4, SOX9 not only overlapped with SOX2 in
the prosensory domain, but showed uniform nuclear ex-
pression in all cells of the cochlear duct epithelium,
similar to that described in the developing mouse coch-
lea [23]. SOX9 was also expressed in the Schwann cells
of the adjacent spiral ganglion (Figure 1C) and in the
cartilage cells of the otic capsule (Figure 1C).
Differentiating cochlear hair cells downregulated SOX9
and SOX10, followed by SOX2
At W12, the openings of the scala vestibuli and the scala
tympani were observed, respectively, above and beneath
the basal turn of the cochlear duct (Figure 1D). The first
morphological signs of hair cell differentiation were then
visible exclusively in the basal turn, as a row of single
cells that emerged facing the luminal aspect of the
SOX2-positive prosensory domain (Figure 1D, E). Im-
munostaining for myosin VIIA (MYO7A), a marker of
hair cells, confirmed this lineage specification (Figure 1F).
Based on the position of the first hair cells at the border
between the prosensory domain (SOX2-positive) and
Kölliker’s organ (SOX2-negative), we identified these
cells as IHCs (Figure 1E) and found that lineage specifi-
cation to IHCs coincided with downregulation of SOX9
(Figure 1F).
At W14 (2 weeks later) the SOX2-positive prosensory
domain is developing into the OC, with maturation
progressing in a basal-to-apical gradient. In the current
study we found that solitary IHCs were differentiated in
the apical and middle turns, whereas in the basal turn,
not only were the IHCs visible, but all three rows of
OHCs (O1, O2, and O3) had formed (Figure 2A-I). In
general, three rows of OHCs were present; however,
Figure 1 SOX2 and SOX9 expression in human fetal cochlea around the onset of first hair cell differentiation. (A) Hematoxylin and eosin
(H&E) staining of a cochlea at W10.4 (week 10 and 4 days) with higher magnification (right panel) of the basal turn cochlear duct. (B) Basal turn of a
W10.4 cochlea immunostained for SOX2, and magnification of the prosensory domain (bottom panels). Cell nuclei were visualized with TO-PRO-3
(red). (C) Basal turn of a W10.4 cochlea immunostained for SOX9, and magnification of the prosensory domain (bottom panels). Cell nuclei were
visualized with TO-PRO-3 (red). (D) H&E staining of a W12 (week 12) cochlea with higher magnification (right panel) of the basal turn cochlear duct.
(E) Basal turn of a W12 cochlea immunostained for SOX2, and magnification of the prosensory domain (bottom panels). Cell nuclei were visualized
with TO-PRO-3 (red). (F) Basal turn of a W12 cochlea immunostained for SOX9 (green) and MYO7A (red), and magnification of the prosensory domain
(bottom panels). Cell nuclei were visualized with DAPI (blue). #Tissue artifact; *, cytoplasmic SOX2 staining in the cochlear duct; $, SOX9 staining in the
otic capsule; bracket, the prosensory domain; white arrow, Schwann cells of the spiral ganglion; arrowhead, inner hair cell. Abbreviations: cd, cochlear
duct; KO, Kölliker’s organ; sv, scala vestibuli; st, scala tympani. Scale bars = 100 μm (all lower magnifications) or 50 μm (all higher magnifications).
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Upon hair cell specification, as confirmed by MYO7A
expression, both IHCs and OHCs showed specific
downregulation of SOX9 (Figure 2A-I), whereas the
supporting cells underneath both IHCs and OHCs
remained positive for both SOX2 and SOX9 (Figure 2A-I).
In the basal turn of the W19 cochlea, all IHCs and
OHCs had become negative for both SOX2 and SOX9,
in contrast to the supporting cells in the OC and in
some of the adjacent cells in Kölliker’s organ, which
expressed SOX2 (Figure 2J,K), acquiring the mature
SOX2/SOX9 expression pattern seen in the mouse OC
[23,32], which has yet to be investigated in the adult hu-
man cochlea. In the developing hair cells, the dynamics
of SOX10 and SOX9 expression were identical (Figure 3).
Downregulation of SOX10 coincided directly with the
first hair cell specification at W12, and expression was
maintained in supporting cells (Figure 3).
At W12 to W19, in the developing OC, either only the
IHCs or the full set of IHCs and OHCs (O1, O2, and O3)
were visible. Therefore, we next investigated whether the
OHCs could be derived from the first differentiated IHCs
by cell division. However, after performing immunostaining
for proliferating cell nuclear antigen (PCNA), a marker ofcycling cells, we found that all cells of the prosensory do-
main had exited the cell cycle at this stage (W10 to W12)
(Figure 4A,B). This strongly suggested that cells in the
prosensory domain/OC do not proliferate, supporting the
idea that the OHCs differentiate from cells in the
prosensory domain, but are not progeny of the IHCs.
At W14, most cells in the cochlear duct, including the
OC cells, were PCNA-negative (Figure 4C).
Innervation of the cochlear duct by PRPH-positive neurites
precedes hair cell differentiation
At W10.4, both PRPH-positive and TUBB3-positive neurites
were present at the distal end of the spiral ganglion in the
basal turn directly beneath the prosensory domain, but these
neurites did not innervate into the epithelium of the coch-
lear duct (Figure 5A). As there are no hair cells yet at this
stage, no cells expressed MYO7A (Figure 5B).
As at W10.4, both PRPH-positive and TUBB3-positive
neurites where still located directly below the prosensory
domain in the W12 apical turn, (Figure 5C). However,
high magnification scanning revealed the presence of
PRPH-positive and TUBB3-positive growth cones extending
a few micrometers into the cochlear epithelium (Figure 5C′,
white and black arrows, respectively), suggesting that in
Figure 2 (See legend on next page.)
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Figure 2 SOX2 and SOX9 expression during development of the human organ of Corti (OC). (A,B) Apical turn of a W14 cochlea
immunostained for (A) SOX2 and (B) SOX9 and magnification of the prosensory domain/OC (A′,B′). Cell nuclei were visualized (red) with
TO-PRO-3. (C) The prosensory domain/OC in the apical turn of a W14 cochlea immunostained for SOX9 (green) and MYO7A (red). Cell nuclei
were visualized with DAPI (blue). (D,E) Middle turn of a W14 cochlea immunostained for (D) SOX2 and (E) SOX9, and (D′,E′) magnification
of the prosensory domain/OC. Cell nuclei were visualized with TO-PRO-3 (red). (F) The prosensory domain/OC in the middle turn of a W14
cochlea immunostained for SOX9 (green) and MYO7A (red). Cell nuclei were visualized with DAPI (blue). (G,H) Basal turn of a W14 cochlea
immunostained for (G) SOX2 and (H) SOX9, and (G′,H′) magnification of the prosensory domain/OC. (I) The prosensory domain/OC in the
basal turn of a W14 cochlea immunostained for SOX9 (green) and MYO7A (red). Cell nuclei were visualized with DAPI (blue). (J,K) Basal turn
of a W19 cochlea immunostained for (G) SOX2 and (H) SOX9. Cell nuclei were visualized with TO-PRO-3 (red). *Cytoplasmic SOX2 staining in
the cochlear duct; bracket, the prosensory domain/OC; arrowhead, inner hair cell. Abbreviations: KO, Kölliker’s organ; IHC, inner hair cell; O1,
first row of outer hair cells; O2, second row of outer hair cells; O3, third row of outer hair cells. Scale bars = (A–K) 50 μm or (A′–H′) 20 μm.
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to signs of hair cell differentiation, as confirmed by the lack
of MYO7A (Figure 5D).
In the W12 middle turn, innervation by both PRPH and
TUBB3 positive neurites advanced further into the epithe-
lium (Figure 5E). These neurites penetrated the basement
membrane at multiple positions directly below the re-
organizing prosensory domain, and seemed directed pre-
dominantly toward one specific cell type, most probably
the first future hair cell to emerge, as the prosensory do-
main remained MYO7A-negative (Figure 5F).
In the W12 basal turn, the neurites progressed upwards
along different routes and contacted the base of the
first differentiated MYO7A-positive hair cells, identified
here as IHCs, at multiple positions along its basal side
(Figure 5G,H). Many neurites seemed to express both
PRPH and TUBB3. Strikingly, single neurites positive for
both PRPH and TUBB3 invaded the epithelium at a more
lateral position, at the site of the future OHCs (Figure 5G,
yellow arrow), suggesting that innervation into the future
OHC area precedes OHC differentiation, just as innerv-
ation into the IHC area precedes IHC differentiation.
PRPH-positive neurites become restricted to the OHC by
W20.3
At W14, the middle turn showed only IHCs (Figure 6A,
B), whereas at W15, the middle turn showed the full
complement of IHCs and OHCs. In both stages, the fullFigure 3 SOX10 expression during human organ of Corti (OC) develo
(green) at (A) W10.4, (B) W12 and (C) W19. Cell nuclei were visualized with
cell. Abbreviations: KO, Kölliker’s organ. Scale bars = 20 μm.complement of IHCs and OHCs was visible in the basal
turn (Figure 6C-F). At W14 to W15, there were abundant
PRPH-positive and TUBB3-positive neurites targeting ba-
sically all the hair cells (IHCs and OHCs) in the middle
and basal turns (Figure 6A-F). At W15, all OHCs (O1,
O2, and O3) were innervated by neurites that followed the
basement membrane, and extended upwards in between
supporting cells, and these neurites ended in a calyx-like
cluster (Figure 6E). Three-dimensional (3D) reconstruc-
tions showed that at W14 and W15, in contrast to W12,
some of these PRPH-positive neurites contacting the
OHCs had already acquired the characteristic ‘spiral’
organization, rather than penetrating the basement
membrane perpendicularly toward the nearest OHC
(see Additional files 1, 2 and 3).
By W18, innervation by PRPH-positive neurites to the
IHCs gradually diminished (Figure 6G) and by W20.3,
PRPH–positive neurites innervated the OHCs exclu-
sively (Figure 6H), similar to the specific innervation
pattern of the adult cochlea [13,31]. 3D reconstruction
revealed the increased to complete ‘spiral’ organization
of the PRPH–positive neurites innervating to the OHC
(see Additional files 4 and 5).
Ubiquitous PRPH expression becomes restricted to type II
SGNs at W18
To further understand the separation of type I and type
II SGNs in humans, we mapped the dynamics of PRPHpment. (A-C) Basal turn of a cochlea immunostained for SOX10
DAPI (blue). Bracket, the prosensory domain/OC; arrowhead, inner hair
Figure 4 Proliferating cell nuclear antigen (PCNA) and SOX9 expression in the basal turn of W10.4 to W14 human fetal cochlea. (A-C)
Basal turn of a cochlea immunostained for PCNA (red) and SOX9 (green) at (A) W10.4, (B) W12 and (C) W14. Cell nuclei were visualized with DAPI
(blue). Bracket, the prosensory domain/OC; arrowhead, inner hair cell. Abbreviations: KO, Kölliker’s organ. Scale bars = 40 μm.
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the developing prosensory domain/OC. At W10 to W15,
both PRPH and TUBB3 expression was visible through-
out the spiral ganglion in the basal turn (Figure 7A-C),
with PRPH expression reaching a maximum at W12.
PRPH-negative but TUBB3-positive nerve fibers were
consistently found near the distal end of the ganglion,
possibly representing the efferent, intra-ganglionic spiral
bundles (Figure 7, black arrows).
Strikingly, by W18, the spiral ganglion was found to be
largely devoid of PRPH (Figure 7D,E). Only some SGNs
strongly expressed PRPH (Figure 7D). Together with the
observation that PRPH-positive neurites become con-
fined to the OHCs and their increase in a spiral orienta-
tion, this suggests the emergence of bona fide type II
SGNs at W18 to W20 in humans.
Initial innervation of the cochlear duct is not conserved
between mouse and human
We have described here that innervation of the cochlear
duct in humans started around W12 and involved the simul-
taneous penetration by PRPH-positive and TUBB3-positive
neurites into the cochlear epithelium. To complement previ-
ous mouse studies that focused specifically on the expressionof PRPH at late and post-natal stages of development (em-
bryonic day 18 (E18) to post-natal day 7 (P7)) [13,14], we in-
vestigated the expression dynamics of PRPH at the start of
penetration of SGN neurites into the mouse cochlear duct,
and the onset of hair cell differentiation. At E13.5, TUBB3
was present only beneath the prosensory domain of the basal
turn of the cochlear duct, as we found in humans at W10
(Figure 8A,B). However, even though some of the neural
structures outside the cochlea showed PRPH positivity
(Figure 8A, white arrow), as well as type II SGNs in
adult mouse cochlea that had been processed identi-
cally in order to confirm correct immunoreactivity (data
not shown), the spiral ganglia in the cochlea of E13.5 mice
were completely PRPH-negative, in contrast to our find-
ings in the human cochlea at W10. Two days later, at
E15.5, innervation by TUBB3-positive neurites was clearly
detected in the basal turn, but innervation by PRPH-
positive neurites was still not seen (Figure 8C-F). It should
be noted that in mice (and humans), innervation of the
epithelium preceded hair cell differentiation, as only a sin-
gle MYO7A-positive IHC was detected in the lower (B1)
basal turn (Figure 8E), but none was seen in the upper
(B2) basal turn, where neurites had already innervated
into the epithelium.
Figure 5 Dynamics of Peripherin (PRPH)-positive and class III β-Tubulin (TUBB3)-positive neurites during first hair cell differentiation.
(A,B) Basal turn of a W10.4 (week 10 and 4 days) cochlea immunostained for (A) PRPH (green) and TUBB3 (red) and (B) MYO7A (red). (C,D) Apical
turn of a W12 cochlea immunostained for (C) PRPH and TUBB3 and MYO7A (D). (C′) Magnification of the prosensory domain in (C). (E,F) Middle
turn of a W12 cochlea immunostained for (E) PRPH and TUBB3 and (F) MYO7A. (G,H) Basal turn of a W12 cochlea immunostained for (G) PRPH
and TUBB3 and (H) MYO7A. Cell nuclei were visualized with DAPI (blue). Bracket, the prosensory domain/OC; arrowhead, inner hair cell; white
arrow, PRPH-positive growth cone; black arrow, TUBB3-positive growth cone; yellow arrow, PRPH/TUBB3-positive neurite. Abbreviations: KO,
Kölliker’s organ. Scale bars = (A-C, D-H) 20 μm or (C′) 5 μm.
Locher et al. Neural Development 2013, 8:20 Page 7 of 13
http://www.neuraldevelopment.com/content/8/1/20Discussion
Differentiation of the IHC at W12
Using transmission electron microscopy, Pujol and
Lavigne-Rebillard previously showed that the onset of first
hair cell differentiation in the human fetal cochlea starts
in W12 of gestation (that is, week 10 of fetal development)
[5]. In the current study, we consistently observed epithe-
lial reorganization in the prosensory domain concurrently
with SOX9 downregulation and MYO7A expression in asingle row of cells in the prosensory domain of the basal
turn, indicating first (inner) hair cell differentiation at
W12. However, in one cochlea from W11.4, there were
identical changes in marker expression in one out of three
sections of the basal turn (see Additional file 6: Figure S1),
even though previous ultrastructural investigations had
reported an undifferentiated poly-layered epithelium [5],
suggesting that hair cell differentiation might already start
at the end of W11.
Figure 6 Dynamics of Peripherin (PRPH)-positive and class III β-Tubulin (TUBB3)-positive neurites during organ of Corti (OC)
maturation. (A,B) Middle turn of a W14 (week 14) cochlea immunostained for (A) PRPH (green) and TUBB3 (red) and (B) MYO7A (red).
(C,D) Basal turn of a W14 cochlea immunostained for (C) PRPH and TUBB3 and (D) MYO7A. (E,F) Basal turn of a W15 cochlea immunostained for
(E) PRPH and TUBB3 and (F) MYO7A. (G) Basal turn of a W18 cochlea immunostained for PRPH and TUBB3. (H) Basal turn of a W20.3 cochlea
immunostained for PRPH and TUBB3. Cell nuclei were visualized with DAPI (blue). Bracket, the prosensory domain/OC; arrowhead, inner hair cell.
Abbreviations: KO, Kölliker’s organ; IHC, inner hair cell; O1, first row of outer hair cells; O2, second row of outer hair cells; O3, third row of outer
hair cells. Scale bars = 20 μm.
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differentiation?
In mammals and other vertebrates, it has been shown
that hair cell differentiation is restricted to cells of the
SOX2-positive prosensory domain [33]. Our data are in
complete agreement with these observations, as we
found that the developing human cochlea at W10.4
exhibited a SOX2-positive prosensory domain in which
hair cell precursors subsequently differentiated into IHCs
and OHCs in a radial and longitudinal gradient. Sox2 hasbeen shown to act on Atoh1, the key transcription factor
for hair cell differentiation [16]. Expression of Atoh1, and
thereby hair cell fate commitment, is also under strict
control of the Notch pathway [34]. Interestingly, there was
downregulation of SOX9 and SOX10 coincident with the
moment of first hair cell commitment, which was followed
several weeks later by downregulation of SOX2. The same
sequence of events for SOX9 and SOX2 has been previ-
ously reported in the developing mouse cochlear duct
[23]. Together with our observations, this supports a
Figure 7 Dynamics of Peripherin (PRPH) and class III β-Tubulin (TUBB3) expression in the human fetal spiral ganglion. (A-E) Basal turn spiral
ganglion immunostained for PRPH (green) and TUBB3 (red) at (A) W10.4 (week 10 and 4 days), (B) W12, (C) W15 and (D) W18. (E) Magnification of the
basal turn spiral ganglion marked with a white arrow in (D). Cell nuclei were visualized with DAPI (blue). White arrow, PRPH-positive spiral ganglion
neurons; black arrow, PRPH-negative and TUBB3-positive nerve fiber bundles. Scale bars = 20 μm.
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commitment, and an evolutionarily conserved mechanism
of hair cell differentiation between mice and humans. It is
known from studies in other tissues that Sox9 is directly
controlled by Notch activity, for example in the develop-
ing nervous system, where it is involved in glial versusneuronal cell fate [35], and in the developing pancreas,
where Sox9 and Notch regulate endocrine versus ductal
cell fate [36]. Sox9 could possibly affect hair cell versus
supporting cell fate in a similar, Notch-dependent manner.
Furthermore, we observed the expression of SOX2 by
supporting cells in the human cochlea up to the final stage
Figure 8 Peripherin (PRPH) and class III β-Tubulin (TUBB3) expression in embryonic day 13.5 (E13.5) and E15.5 mouse cochlea.
(A,B) E13.5 mouse cochlea immunostained (A) for PRPH (green) and TUBB3 (red) and (B) magnification of the prosensory domain of basal
turn B1. (C-F) E15.5 mouse cochlea (C) immunostained for PRPH and TUBB3, (D) magnification of the prosensory domain of basal turn B1,
(E) magnification of the prosensory domain of basal turn B1 immunostained for TUBB3 (red) and MYO7A (green), and (F) magnification of
the prosensory domain of basal turn B2 immunostained for PRPH (green) and TUBB3 (red). Cell nuclei were visualized with DAPI (blue).
Bracket, the prosensory domain; arrowhead, inner hair cell. Abbreviations: KO, Kölliker’s organ. Scale bars = (A,C) 100 μm or (B, D-F) 10 μm.
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Sox2 expression in supporting cells is linked to a dormant
potential of hair cell differentiation [37], this validates
(animal) research focusing on this pathway to restore
hearing. SOX2 expression in the adult human cochlea re-
mains to be investigated.
Innervation dynamics of the cochlear duct by PRPH-positive
neurites
Hair cell development progresses hand in hand with the
arrival and shaping of afferent neurites into the cochlear
duct epithelium [11]. In contrast to mice, human PRPH
was expressed in SGNs prior to hair cell innervation,and the dynamics in the spiral ganglion correlated per-
fectly with the initial steps of innervation within the de-
veloping OC in humans. We found abundant PRPH
expression at W12 and W15 in SGN cell bodies and in
neurites reaching both the IHCs and OHCs. At W18,
PRPH expression had become limited to cells generally
located at the distal end of the spiral ganglion. It is well
known that type II SGNs in the adult human cochlea are
also found mainly in this area [12]. In addition, in the
adult human cochlea, type II SGNs represent less than
10% of the total number of SGNs [12], and PRPH ex-
pression has been found to be restricted to this cell type
[31]. In relation to our observations, it can therefore be
Figure 9 Schematic diagram of neurosensory development in
the basal turn of the human fetal cochlea. At W10 (week 10),
SOX2 identifies the prosensory domain within the SOX9/SOX10+
cochlear duct epithelium. Neurites from the adjoining TUBB3+/PRPH +
SGNs do not yet penetrate into the epithelium. Penetration starts at
W11, prior to hair cell differentiation. At W12, the first MYO7A+/SOX9-/
SOX10-/SOX2+ (inner) hair cell can be seen, and is contacted by
multiple TUBB3+ and PRPH + neurites. Penetrating neurites are also
found at the location of the future OHCs. At W14, both the IHCs and
OHCs have differentiated, and neurites underneath the OHCs start to
run in a spiral direction. At this stage, hair cells still express SOX2. At
W20, SOX2 is downregulated in all hair cells, as opposed to the other
cells in the organ of Corti. PRPH expression distinguishes between type
I (PRPH-) and type II (PRPH+) neurites. Abbreviations: SGN, spiral
ganglion neuron; IHC, inner hair cell; O1, first row of outer hair cells; O2,
second row of outer hair cells; O3, third row of outer hair cells; OHC,
outer hair cell.
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stricted to type II SGNs by W18-W20.
Onset of human hearing by W20?
Complete absence of PRPH-positive neurites projecting
to IHCs was observed at W20. At this gestational stage,
the IHCs were abundantly innervated by TUBB3-positive
neurites. The spiral orientation of neurites projecting to
OHCs was already found at W14 to W15, and was prom-
inently present at W20. These observations are in line
with adult expression patterns and orientation, providing
further support for the timing of onset of human coch-
lear function, which is thought to take place around
W20 [9-11].
Conclusions
In conclusion, this work (summarized in Figure 9) pro-
vides some much-needed insight into the development
of the human cochlea. We have shown that a SOX2-
positive prosensory domain exists within the fetal hu-
man cochlear duct. Furthermore, the results presented
here support the notion that SOX2 and SOX9/SOX10
may have different roles in hair cell versus supporting
cell fate determination. Our investigations into hair cell
innervation have shown that both TUBB3-positive and
PRPH-positive neurites penetrate the basement mem-
brane of the cochlear epithelium as early as W12 and
target the subsequent developing first hair cell. This in
contrast to the mouse, in which PRPH expression is
detected later. Finally, we determined that already by
W18 to W20, PRPH expression distinguishes between
type I and type II SGNs, in contrast to mice and other
rodents, in which this specialization occurs only during
post-natal development of the cochlea [13,14,38]. To-
gether, these results bring us closer to understanding the
timing of some of the essential steps and the identifica-
tion of some of the key molecular players during human
cochlear development. Thus, we provide a basis for re-
search focused on regeneration of the auditory system
and restoration of hearing.
Methods
Ethics approval
The medical ethics committee of the Leiden University
Medical Center approved this study (protocol 08.087),
and informed consent was obtained in accordance with
the WMA Declaration of Helsinki guidelines.
Tissue samples
In total, 27 human embryonic and fetal cochleae were
collected from tissue obtained by elective termination of
pregnancy (by vacuum aspiration, after obstetric ultra-
sonography to determine gestational age in weeks and
days) at various gestational stages (W10 to W20: W10,
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http://www.neuraldevelopment.com/content/8/1/20n = 4; W11, n = 1; W12, n = 4; W14, n = 4; W15, n = 2;
W16, n=1; W17, n= 4; W18, n=4; W19, n=2; W20, n=1).
Time between termination and collection was kept to
a minimum, ranging from one to several hours. All
cochlear specimens were fixed in 4% paraformaldehyde
in PBS overnight at 4°C. Cochleae obtained before W14
were dehydrated in ethanol and embedded in paraffin
wax using standard procedures. Cochleae from W14 and
later were decalcified for 1 to 3 weeks in 10% EDTA
disodium salt (pH 7.4) (Sigma-Aldrich, St Louis, MO,
USA) in distilled water at 4°C, prior to ethanol dehydra-
tion and paraffin wax embedding. Sagittal sections from
E13.5 and E15.5 mouse embryos (CBA/Bl6) were a gen-
erous gift from the McLaren Laboratory (Wellcome
Trust/Cancer Research UK Gurdon Institute, University
of Cambridge, Cambridge, UK). For these, E0.5 was des-
ignated as the first morning with a vaginal plug, and tis-
sue was fixed in 4% paraformaldehyde in PBS overnight
at 4°C before paraffin wax embedding.
Histology and immunofluorescence
The cochleae were sectioned (5 μm) in the sagittal plane
using a RM2255 microtome (Leica Microsystems GmbH,
Wetzlar, Germany). Sections were dewaxed in xylene,
rehydrated in a descending ethanol series (100%, 90%,
80%, 70%), and rinsed in distilled water. Hematoxylin and
eosin staining was performed by standard procedures to
determine the morphology of each cochlea. For immuno-
fluorescence, antigen retrieval was performed in 0.01 mol/
l sodium citrate buffer (pH 6.0) for 12 minutes at 97°C
using a microwave oven, and sections were allowed to
cool to room temperature. The sections were subse-
quently blocked with 1% bovine serum albumin (BSA;
Sigma-Aldrich) in PBS containing 0.05% Tween-20
(Promega, Leiden, the Netherlands) for 30 minutes, and
incubated with primary antibodies diluted in blocking so-
lution overnight at room temperature in a humidified
chamber. The following day, the sections were incubated
with secondary antibodies diluted in blocking solution for
2 hours at room temperature. Nuclei were stained with
4′,6-diamidino-2-phenylindole (DAPI; Vector Laboratories
Ltd., Peterborough, UK) or TO-PRO-3 (Life Technologies,
Carlsbad, CA, USA), and sections were mounted in Pro-
Long Gold (Life Technologies). The primary antibodies
used in this study were mouse anti-MYO7A (1:40; 138-1
supernatant; DSHB, Iowa City, IA, USA), rabbit anti-SOX2
(1:200; ab5603), rabbit anti-PRPH (1:200; ab1530) (both
Chemicon, Temecula, CA, USA); rabbit anti-SOX9 (1:200;
ab5535, Millipore Corp., Bedford, MA, USA), goat anti-
SOX10 (1:50; sc-17342), mouse anti-PCNA (1:500;, ab-56)
(both Santa Cruz Biotechnologies, Santa Cruz, CA,
USA), and mouse anti-TUBB3 (1:200; ab78078, Abcam,
Cambridge, UK). The Alexa Fluor conjugated secondary
antibodies used were 488 donkey anti-mouse (1:500;A-21202), 488 donkey anti-rabbit (1:500; A-21206),
488 donkey anti-goat (1:500; A-11055), 568 donkey
anti-mouse (1:500; A-10037) and 568 donkey anti-rabbit
(1:500; A-10042 (all Life Technologies)). For antibody spe-
cificity controls, primary antibodies were omitted.
Image acquisition and processing
Sections stained with hematoxylin and eosin were digi-
tized using a Pannoramic MIDI scanner (3DHISTECH,
Kisvárda, Hungary) and adjusted using Pannoramic
Viewer (3DHISTECH). Confocal images were taken
under a Leica TCS SP5 confocal inverted microscope
(Leica Microsystems), operating with the Leica Applica-
tion Suite Advanced Fluorescence software (LAS AF;
Leica Microsystems). Sections were scanned throughout
their full depth with Z-steps of 0.5 μm (or with a sam-
pling density according to the Nyquist rate in the case of
high magnification) and Z-projections were generated.
Brightness and contrast adjustments, consistent with the
image manipulation policy, were performed either in
LAS AF or Adobe Photoshop CS6 (Adobe Systems Inc.,
San José, CA, USA). Amira (version 4.1; Visage Imaging,
San Diego, CA, USA) was used for 3D reconstruction of
entire Z-stacks.
Additional files
Additional file 1: Movie 1. Three-dimensional reconstruction showing
the PRPH-positive neurites (green) and the nucleus of the inner hair cell
(blue) of the prosensory domain/developing organ of Corti in the lower
basal turn at W12, (week 12) corresponding to Figure 5G.
Additional file 2: Movie 2. Three-dimensional reconstruction showing
the Peripherin (PRPH)-positive neurites (green) and the nuclei of the hair
cells (blue) of the developing organ of Corti in the lower basal turn at
W14 (week 14), corresponding to Figure 6C.
Additional file 3: Movie 3. Three-dimensional reconstruction showing
the Peripherin (PRPH)-positive neurites (green) and the nucleus of the
inner hair cell (blue) of the developing organ of Corti in the lower basal
turn at W15 (week 15), corresponding to Figure 6E.
Additional file 4: Movie 4. Three-dimensional reconstruction showing
the Peripherin (PRPH)-positive neurites (green) and the nucleus of the
inner hair cell (blue) of the developing organ of Corti in the lower basal
turn at W18 (week 18), corresponding to Figure 6G.
Additional file 5: Movie 5. Three-dimensional reconstruction showing
the Peripherin (PRPH)-positive neurites (green) and the nucleus of the
inner hair cell (blue) of the developing organ of Corti in the lower basal
turn at W20.3 (week 20.3), corresponding to Figure 6H.
Additional file 6: Figure S1. The onset of hair cell differentiation.
Confocal image of the prosensory domain within the lower basal turn of
a W11.4 human fetal cochlea immunostained for MYO7A (red) and SOX9
(green). Nuclei were visualized (blue) with DAPI. Bracket, prosensory
domain; arrowhead, inner hair cell. Scale bar = 20 μm.
Abbreviations
3D: Three-dimensional; CO: Organ of Corti; DAPI: 4′,6-diamidino-2-
phenylindole; IHC: Inner hair cell; KO: Kölliker’s organ; MYO7A: Myosin VIIA;
O1: First row of outer hair cells; O2: Second row of outer hair cells; O3: Third
row of outer hair cells; OHC: Outer hair cell; PCNA: Proliferating cell nuclear
antigen; PRPH: Peripherin; SGN: Spiral ganglion neuron; TUBB3: Class III
β-Tubulin.
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